drugset

drugset / Trial / NCT00316160

Sexual Functioning Study With Antidepressants

NCT00316160 ↗

Phase 4 Completed 347 enrolled GlaxoSmithKline

RandomizedParallel-groupDouble-blindTreatment

Summary

Effects of two depression medication on sexual functioning

Timeline

Start: 2004-09
Primary completion: 2005-05
Completion: 2005-05

Publications

Results Thase ME, Clayton AH, Haight BR, Thompson AH, Modell JG, Johnston JA. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. J Clin Psychopharmacol. 2006 Oct;26(5):482-8. doi: 10.1097/01.jcp.0000239790.83707.ab.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bupropion	Small molecule	150 mg	—
Subject	Bupropion	Small molecule	450 mg	—
Subject	Venlafaxine	Small molecule	75 mg	—
Subject	Venlafaxine	Small molecule	225 mg	—

Indications